A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Allergan

Status and phase: Completed; Phase 3

Conditions: Cataract Extraction

Treatments: Drug: ketorolac eye drops

Study type: Interventional

Funder types: Industry

Identifiers

NCT00521456

191578-006

Details and patient eligibility

About

This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery

Enrollment: 263 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing cataract surgery

Exclusion criteria

• Uncontrolled ocular disease in cataract surgery eye

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

263 participants in 2 patient groups, including a placebo group

1

Experimental group

Treatment:

Drug: ketorolac eye drops

2

Placebo Comparator group

Treatment:

Drug: ketorolac eye drops